Home > Insider Trading > Filing (0000897069-23-000269)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533743	Processa Pharmaceuticals Inc.	PCSA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378166	David Young	C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-04-11	20,000	$0.52	370,424	No	4	P	Direct
Common Stock	Acquisiton	2023-04-12	20,000	$0.45	390,424	No	4	P	Direct
Common Stock	Acquisiton	2023-04-13	20,000	$0.48	410,424	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	619,677	Indirect	By Young-Plaisance Revocable Trust
Common Stock	215,703	Indirect	By Family Entities
Common Stock	370,887	Indirect	By CorLyst, LLC

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.49 to $0.53, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.44 to $0.51, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.